Evidence map›Paper›PMID 38675469›Full record

ReviewPharmaceuticals (Basel, Switzerland)2024

Unveiling the Potential of

Shadrack Kibet, Njogu M Kimani, Syombua S Mwanza, Cynthia M Mudalungu, Cleydson B R Santos, Chrysantus M Tanga

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Molecules (Basel, Switzerland) · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Semisynthesis and Antitumour Evaluation of Natural Derivatives fromInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Shadrack KibetDepartment of Physical Sciences, University of Embu, Embu P.O. Box 6-60100, Kenya.ORCID 0000-0002-0784-6610
Njogu M KimaniDepartment of Physical Sciences, University of Embu, Embu P.O. Box 6-60100, Kenya.ORCID 0000-0002-5171-1940
Syombua S MwanzaDepartment of Physical Sciences, University of Embu, Embu P.O. Box 6-60100, Kenya.
Cynthia M MudalunguInternational Centre of Insects Physiology and Ecology, Nairobi P.O. Box 30772-00100, Kenya.ORCID 0000-0002-2111-3974
Cleydson B R SantosGraduate Program in Medicinal Chemistry and Molecular Modelling, Health Science Institute, Federal University of Pará, Belém 66075-110, Brazil.ORCID 0000-0002-0271-335X
Chrysantus M TangaInternational Centre of Insects Physiology and Ecology, Nairobi P.O. Box 30772-00100, Kenya.ORCID 0000-0002-5788-7920
International Centre of Insect Physiology and Ecology · KETechnical University of Kenya · KEUniversidade Federal do Amapá · BRUniversity of Embu · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products hold immense potential for drug discovery, yet many remain unexplored in vast libraries and databases. In an attempt to fill this gap and meet the growing demand for effective drugs, this study delves into the promising world of

Indexed as

ADMET propertiesditerpenoidsdrug-likenessent-kauranesnatural productspharmacokinetics

Identifiers

PMID38675469
PMCPMC11054903
OpenAlexW4394836726

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.